Eli Lilly and Company discovers, develops, manufactures, and markets human pharmaceutical products in the United States, Europe, China, Japan, and internationally. The company offers cardiometabolic health products, including Basaglar, Huma…
HQ: Indianapolis, IN, United States of Americawww.lilly.com
USD1,443.50+1.14%vs prev. close
Performance
1W
+4.58%
1M
+22.35%
3M
+18.05%
1Y
+40.23%
YTD
+32.81%
Valuation
P/E
46.3
EPS TTM
30.81
Dividend yield
0.48%
Size and risk
Market cap
$1.27T
Beta
0.39
Price history
LLY price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
Eli Lilly
LLY
Drug Manufacturers - General
Mkt cap (USD bn)
1271.3
P/E
46.3
Div yld
0.48%
1W
+4.6%
1M
+22.4%
3M
+18.1%
6M
+41.8%
1Y
+40.2%
YTD
+32.8%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Eli Lilly
LLY
Drug Manufacturers - General
1271.3
46.3
0.48%
+4.6%
+22.4%
+18.1%
+41.8%
+40.2%
+32.8%
Subscribe to Equity Analytics to compare LLY with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.